Literature DB >> 19365894

Critical appraisal of outcomes following open radical prostatectomy.

David J Galvin1, James A Eastham.   

Abstract

PURPOSE OF REVIEW: Radical prostatectomy has evolved enormously over the last 25 years. Improvements include the use of smaller incisions, reduced blood loss, shorter hospital stays, and surgical refinement to improve the recovery of continence and potency. In addition, new technologies and minimally invasive techniques with the potential to further improve patient outcomes have been introduced. This article focuses on outcomes with open radical prostatectomy and is not meant to compare open radical prostatectomy and minimally invasive approaches. RECENT
FINDINGS: Despite a lack of randomized controlled trials, strong observational cohort studies demonstrate lower rates of positive surgical margins, high 10-year and 15-year biochemical recurrence-free rates, excellent prostate cancer-specific mortality rates, and improved recovery of urinary incontinence and erectile function after open radical prostatectomy. We review publications from the past 24 months regarding oncologic outcome, continence, and erectile function, as well as some earlier manuscripts that emphasize key aspects of open radical prostatectomy.
SUMMARY: Today open radical prostatectomy is a less-invasive procedure with low morbidity providing excellent control of clinically localized prostate cancer. Although open radical prostatectomy now accounts for a minority of radical prostatectomies in the United States, the concepts that have improved oncologic and quality-of-life outcomes are equally applicable to minimally invasive procedures.

Entities:  

Mesh:

Year:  2009        PMID: 19365894     DOI: 10.1097/mou.0b013e328329eb13

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  4 in total

1.  68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery.

Authors:  Rohan Nandurkar; Pimmeke van Leeuwen; Phillip Stricker; Henry Woo; Rajdeep Kooner; Carlo Yuen; Gordon O'Neill; David Ende; Thomas Cusick; Bao Ho; Adam Hickey; Louise Emmett
Journal:  Br J Radiol       Date:  2019-01-23       Impact factor: 3.039

2.  Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block.

Authors:  Maitreyee K Jathal; Liqun Chen; Maria Mudryj; Paramita M Ghosh
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011-06

3.  Contemporary radical prostatectomy.

Authors:  Qiang Fu; Judd W Moul; Leon Sun
Journal:  Prostate Cancer       Date:  2011-04-14

4.  A new technique of bladder neck reconstruction during radical prostatectomy in patients with prostate cancer.

Authors:  Yuri Tolkach; Konstantin Godin; Sergey Petrov; Sonny Schelin; Florian Imkamp
Journal:  Int Braz J Urol       Date:  2015 May-Jun       Impact factor: 1.541

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.